D81.819
Biotin-dependent carboxylase deficiency, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Multiple carboxylase deficiency, unspecified
Medical Intelligence & Overview
Biotin-dependent carboxylase deficiency is a rare metabolic disorder that affects the body's ability to process certain nutrients properly. This condition stems from a deficiency in specific enzymes called biotin-dependent carboxylases, which play a crucial role in various metabolic pathways. When these enzymes malfunction or are deficient, it can lead to a buildup of toxic substances and a shortage of vital compounds necessary for energy production and cell function. Although the precise causes can vary, this disorder is classified under ICD-10 code D81.819, indicating an unspecified version of the condition. Recognizing the signs and understanding its underlying mechanisms are essential steps toward management and treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting biotin-dependent enzymes, leading to decreased activity or deficiency. Insufficient dietary intake of biotin, a vital B-vitamin, though this is a less common cause. Malabsorption syndromes that impair the absorption of biotin from the gastrointestinal tract. Certain medications or treatments that interfere with biotin metabolism or utilization. Secondary causes such as chronic illnesses impacting biotin levels or enzyme function.
Key Symptoms: Weakness and fatigue due to impaired energy metabolism. Developmental delays or neurodevelopmental issues, particularly in infants and children. Skin rashes or dermatitis, often around the eyes or nose. Hair thinning or alopecia. Nausea, vomiting, and loss of appetite. Lethargy or decreased muscle tone. Possible neurological symptoms such as seizures or hypotonia. Episodes of metabolic acidosis—an abnormal level of acid in the blood. Respiratory difficulties in severe cases.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of biotin-dependent carboxylase deficiency involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Blood tests may reveal metabolic imbalances, such as elevated levels of biotinidase or associated metabolites. Enzyme activity assays can determine the functionality of biotin-dependent carboxylases. In some cases, genetic testing identifies mutations in genes responsible for these enzymes. A thorough medical history and physical examination help in assessing developmental milestones, skin, and hair condition, enabling healthcare providers to make an accurate diagnosis.
Treatment Protocols: Treatment primarily involves nutritional management and supplementation. High-dose biotin supplements are commonly administered to compensate for the deficiency and restore enzyme activity. Early initiation of treatment can prevent or reduce symptoms and complications. Regular monitoring of biochemical parameters is essential to assess response and adjust dosage as needed. Supportive therapies, such as physical and occupational therapy, may be recommended for developmental or neurological symptoms. In some cases, dietary modifications may be advised to ensure adequate nutrient intake. Genetic counseling could be beneficial for affected families to understand inheritance patterns and risks.
Clinical Advice & FAQs
Billing Guidance
Is D81.819 a billable ICD-10 code?
Yes, D81.819 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D81.819?
Clinical documentation must specify the nature of Biotin-dependent carboxylase deficiency, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference